Horizon Pharma CEO Timothy Walbert's 2020 pay jumps 56% to $22M
Horizon Pharma reports 2020 executive compensation
By ExecPay News
Published: March 17, 2022
Horizon Pharma reported fiscal year 2020 executive compensation information on March 17, 2022.
In 2020, six executives at Horizon Pharma received on average a compensation package of $7.9M, a 56% increase compared to previous year.
Average pay of disclosed executives at Horizon Pharma
Timothy P. Walbert, Chief Executive Officer, received $22M in total, which increased by 56% compared to 2019. 75% of Walbert's compensation, or $16M, was in stock awards. Walbert also received $4.1M in non-equity incentive plan, $1.1M in salary, as well as $200K in other compensation.
For fiscal year 2020, the median employee pay was $298,446 at Horizon Pharma. Therefore, the ratio of Timothy P. Walbert's pay to the median employee pay was 72 to one.
Paul W. Hoelscher, Chief Financial Officer, received a compensation package of $5.9M, which increased by 33% compared to previous year. 68% of the compensation package, or $4M, was in stock awards.
Andy Pasternak, Executive Vice President, Chief Strategy Officer, earned $5.8M in 2020, a 99% increase compared to previous year.
Jeffrey W. Sherman, M.D., FACP, Chief Medical Officer, received $5.3M in 2020, which increases by 47% compared to 2019.
Barry J. Moze, Chief Administrative Officer, earned $5.1M in 2020, a 9% increase compared to previous year.
Brian K. Beeler, General Counsel, received $3.8M in 2020, which increases by 17% compared to 2019.
Related executives
Brian Beeler
Horizon Pharma
General Counsel
Timothy Walbert
Horizon Pharma
Chief Executive Officer
Paul Hoelscher
Horizon Pharma
Chief Financial Officer
Andy Pasternak
Horizon Pharma
Executive Vice President, Chief Strategy Officer
Jeffrey FACP
Horizon Pharma
Chief Medical Officer
Barry Moze
Horizon Pharma
Chief Administrative Officer
You may also like
Source: SEC filing on March 17, 2022.